Li, X., Li, S., Li, B., Li, Y., Aman, S., Xia, K., . . . Wu, H. (2021). Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1. Nature Portfolio.
Chicago Style (17th ed.) CitationLi, Xiahui, Shujing Li, Bowen Li, Yanan Li, Sattout Aman, Kangkai Xia, Yuxi Yang, Bashir Ahmad, and Huijian Wu. Acetylation of ELF5 Suppresses Breast Cancer Progression by Promoting Its Degradation and Targeting CCND1. Nature Portfolio, 2021.
MLA (8th ed.) CitationLi, Xiahui, et al. Acetylation of ELF5 Suppresses Breast Cancer Progression by Promoting Its Degradation and Targeting CCND1. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.